Revenue segments as reported by the company.

Net revenue, before excise taxes

Excise taxes

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Sales and marketing

Research and development

General and administrative

Restructuring costs

Share-based payments

Depreciation and amortization

Impairment loss on goodwill and indefinite-lived intangible assets

Impairment loss on long-lived assets

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Cronos Group

Cronos Group, Inc. engages in the production and distribution of cannabis. Its brands include PEACE NATURALS, COVE, Spinach, Lord Jones, and PEACE+. The company was founded by Lorne Michael Gertner and Paul Rosen on August 21, 2012 and is headquartered in Toronto, Canada.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Cronos Group, Inc. engages in the production and distribution of cannabis. I It operates through the Canada and Israel segments. The company was founded on August 21, 2012 and is headquartered in Toronto, Canada.

Advanced Micro Devices

Uber

Kraft Heinz

Microsoft

Uber, Microsoft, AMD, Kraft Heinz and Cronos Group are our top stock trades. Here's how to trade them now.

5 Top Stock Trades for Friday (Aug 09)

The cannabis company more than triples its revenue figure.

Cronos Group's Q2 Trounces Estimates

Cronos Group Inc. (CRON) CEO Mike Gorenstein on Q2 2019 Results - Earnings Call Transcript

Shares of Cronos Group Inc (NASDAQ: CRON) traded higher Thursday morning after the cannabis company reported a four-fold jump in revenue year-over-year in its second quarter results.

Cronos Group Trades Higher After Revenue Jumps Three-Fold In Q2

Canadian cannabis company Cronos Group Inc.'s shares CRON, +4.49% CRON, +3.81% rose 8% in premarket trade Thursday, after the company posted stronger-than-expected earnings for the second quarter.

Canadian cannabis company Cronos stock soars 8% premarket after earnings beat

Cronos Group earnings: A Q2 profit defied views for a slim loss. Revenue tripled.

Cronos Group Earnings Surprise As Revenue Triples; Marijuana Stock Jumps

Canopy Growth

Tilray Brands

The U.S. is where the big money will be made in cannabis.

3 Canadian Cannabis Stocks With the Best U.S. Strategies

Investors will focus on Cronos' (CRON) regular top and bottom-line numbers along with its pipeline progress when it reports second-quarter results.

Cronos (CRON) to Report Q2 Earnings: What's in the Cards?

Cronos Group just did something that no major cannabis stock has done before.

Here's Why Cronos Group's CBD Acquisition Is So Unique

Cronos will report its second-quarter results this week. Here’s a look of what to expect from CRON stock, and a look at the past quarter.

Cronos Stock: What To Expect From This Week’s Earnings Report

Altria

The tobacco giant's $1.8 billion investment isn't going up in smoke. Cronos appears to be using its big cash stockpile wisely.

Why Investors Should Like How Cronos Group Is Spending Altria's Money (So Far)

Cronos Group Inc (NASDAQ: CRON) on Friday announced a $300 million buyout of U.S.

Analyst: Cronos-Redwood Deal 'Just The Tip Of The Iceberg'

CannTrust Holdings

HEXO Corp

MedMen Enterprises Inc.

Aurora Cannabis

Aphria

OrganiGram Holdings Inc.

The outlook for cannabis stocks isn't nearly as green as it used to be.

Earnings Estimates Are Plunging for These 12 Pot Stocks

The company is paying around $300 million for the owner of the Lord Jones line of CBD products.

Cronos Group Acquires CBD Beauty Line Producer

GW Pharmaceuticals

Cannabis stocks bounced back on Friday, trading higher in sympathy with a big earnings beat and 35% gain from Aphria Inc (NYSE: APHA).

Cannabis Stocks Are The Latest Target Of Short Sellers

CVS Health

Disney

The peak of earnings season has passed, but there are still earnings reports next week with large implications for stocks and their sectors.

3 Earnings Reports to Watch Next Week: CRON, CVS & DIS

Cronos Group agreed to buy parts of a CBD company that sells products in the U.S. Cronos Group stock and most other marijuana stocks rallied.

Marijuana Stock Cronos Rises As $300 Million Hemp Deal Extends Reach In U.S.

Cronos will acquire Redwood Holding Group, the company behind popular CBD beauty brand Lord Jones, for $300 million, the pot company announced Friday.

Canadian pot company Cronos gets foothold in US by buying popular CBD beauty brand Lord Jones

Cronos Group Inc (NASDAQ: CRON) announced Friday it reached an agreement to acquire a CBD company with exposure to the United States.

Cronos To Acquire 4 Redwood Subsidiaries, Expand Growth In US CBD Market

Canadian cannabis company Cronos Group Inc. CRON, -7.82% CRON, -7.65% said Friday it has agreed to acquire four units of Redwood Holding Group LLC, a maker of hemp-derived CBD-infused skincare and other products, for $300 million in stock and cash.

Cronos to acquire four Redwood Holding subsidiaries for $300 million in cash and stock

With full commercial marijuana in the United States years away, there is plenty of time to place your bets on the cannabis sector. With the market overvalued, it may pay to wait things out until a screaming buy emerges.

There Are Better Pot Plays Than CRON Stock

The bull thesis on CRON stock continues to lack conviction given the stock's persistent over-valuation issues.
The post As Strong as It Looks, Now Is Not the Time to Buy Cronos Stock appeared first on InvestorPlace.

As Strong as It Looks, Now Is Not the Time to Buy Cronos Stock

Cronos Group (CRON) closed the most recent trading day at $13.81, moving -0.79% from the previous trading session.

Cronos Group (CRON) Stock Moves -0.79%: What You Should Know

In the next few quarters, marijuana stocks will trade higher if the underlying company reports higher revenue and shrinking operating costs. The closer the company reaches profitability, the more likely the stock will rebound.

News for Cronos Group Stock (CRON)